体外受精、宫内人工授精或女性不孕是否影响单胎先天畸形风险?法国全国纵向研究
多因素调整后,新鲜胚胎移植和冻融胚胎移植与畸形风险增加相关(aOR分别为1.15和1.13),宫内人工授精风险不再显著(aOR 1.01),而母亲子宫内膜异位症、多囊卵巢综合征和早发性卵巢功能不全独立增加风险。
要点
- 新鲜胚胎移植和冻融胚胎移植后单胎先天畸形风险较自然受孕增加。
- 宫内人工授精后先天畸形风险与自然受孕相似。
- 母亲子宫内膜异位症、多囊卵巢综合征和早发性卵巢功能不全独立增加畸形风险。
核心结论
- 多因素调整后,宫内人工授精与先天畸形风险无显著关联。
- 新鲜胚胎移植和冻融胚胎移植与先天畸形风险轻度增加相关。
- 母亲潜在不孕(子宫内膜异位症、多囊卵巢综合征、早发性卵巢功能不全)独立增加先天畸形风险。
研究设计与样本
- 随访至儿童早期(至少2.5岁),采用多因素logistic回归调整母亲年龄、初产、肥胖、吸烟、高血压或糖尿病史及女性不孕。
主要发现
- 先天畸形总体患病率:自然受孕3.78%、新鲜胚胎移植4.53%、冻融胚胎移植4.39%、宫内人工授精3.91%。
- 与自然受孕相比,新鲜胚胎移植aOR 1.15(95%CI 1.10-1.20,P<0.0001),冻融胚胎移植aOR 1.13(95%CI 1.05-1.21,P=0.001)。
- 宫内人工授精与自然受孕总体风险相似,aOR 1.01(95%CI 0.94-1.08,P=0.81)。
- 母亲子宫内膜异位症aOR 1.16(95%CI 1.10-1.22,P<0.0001)、多囊卵巢综合征aOR 1.20(95%CI 1.08-1.34,P=0.001)、早发性卵巢功能不全aOR 1.52(95%CI 1.23-1.88,P=0.0001)。
临床怎么用
- 咨询接受辅助生殖技术者时,应告知新鲜胚胎移植和冻融胚胎移植后单胎先天畸形风险轻度升高。
- 宫内人工授精后先天畸形风险与自然受孕相近,可据此进行风险沟通。
- 评估先天畸形风险时应考虑母亲潜在不孕病因(子宫内膜异位症、多囊卵巢综合征、早发性卵巢功能不全)。
局限性
- 未纳入男方不孕因素、体外受精方式(常规体外受精与卵胞浆内单精子注射)及移植胚胎阶段。
- 不能排除残余混杂,且三种女性不孕的诊断标准存在不确定性。
- 部分亚组畸形病例数少,特定畸形的结果需谨慎解读(可能为I类错误或多重检验)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Do IVF, IUI or female infertility (i.e. endometriosis, polycystic ovary syndrome [PCOS] and primary ovarian insufficiency [POI]) lead to an increased risk of congenital anomalies in singletons? SUMMARY ANSWER: After multivariable adjustments, the increased risks of congenital defects associated with IUI were no longer significant, but the underlying maternal infertility presented a potential emental risk, in addition to the risk associated with IVF. WHAT IS KNOWN ALREADY: Most epidemiological studies suggest that singletons born from ART have a higher risk of birth defects, specifically musculoskeletal, cardiovascular and urogenital disorders. However, most of these studies were established on data obtained at birth or in the neonatal period and from relatively small populations or several registries. Moreover, to our knowledge, female infertility, which is a potential confounder, has never been included in the risk assessment. STUDY DESIGN, SIZE, DURATION: Using data from the French National Health System database, we conducted a comparative analysis of all singleton births (deliveries ≥22 weeks of gestation and/or >500 g of birthweight) in France over a 5-year period (2013-2017) resulting from fresh embryo or frozen embryo transfer (fresh-ET or FET from IVF/ICSI cycles), IUI and natural conception (NC). Data were available for this cohort of children at least up to early childhood (2.5 years old). PARTICIPANTS/MATERIALS, SETTING, METHODS: A total of 3 501 495 singleton births were included (3 417 089 from NC, 20 218 from IUI, 45 303 from fresh-ET and 18 885 from FET). Data were extracted from national health databases and used to identify major birth defects. Malformations were classified according to the 10th revision of the International Classification of Disease. To analyse the effect of mode of conception, multivariable analyses were performed with multiple logistic regression models adjusted for maternal age, primiparity, obesity, smoking, history of high blood pressure or diabetes and female infertility. MAIN RESULTS AND THE ROLE OF CHANCE: In our cohort of children, the overall prevalence of congenital malformations was 3.78% after NC, 4.53% after fresh-ET, 4.39% after FET and 3.91% after IUI (132 646 children with major malformations). Compared with infants conceived naturally, children born after fresh-ET and after FET had a significantly higher prevalence of malformations, with an adjusted odds ratio (aOR) of 1.15 [95% CI 1.10-1.20, P < 0.0001] and aOR of 1.13 [95% CI 1.05-1.21, P = 0.001], respectively. Among the 15 relevant subgroups of malformations studied, we observed a significantly increased risk of eight malformations in the fresh-ET group compared with the NC group (i.e. musculoskeletal, cardiac, urinary, digestive, neurological, cleft lip and/or palate and respiratory). In the FET group, this increased risk was observed for digestive and facial malformations. The overall risk of congenital malformations, and the risk by subtype, was similar in the IUI group and the NC group (overall risk: aOR of 1.01 [95% CI 0.94-1.08, P = 0.81]). In addition, there was an overall independent increase in the risk of congenital defects when the mothers were diagnosed with endometriosis (1.16 aOR [95% CI 1.10-1.22], P < 0.0001), PCOS (1.20 aOR [95% CI 1.08-1.34], P = 0.001) or POI (1.52 aOR [95% CI 1.23-1.88], P = 0.0001). Chromosomal, cardiac and neurological anomalies were more common in the three maternal infertility groups. LIMITATIONS, REASONS FOR CAUTION: Male infertility, the in vitro fertilization method (i.e. in vitro fertilization without or with sperm injection: conventional IVF vs ICSI) and embryo stage at transfer could not be taken into account. Furthermore, residual confounding cannot be excluded as well as uncertainties regarding the diagnostic criteria used for the three female infertilities. Findings for specific malformations should be interpreted with caution because the number of cases was small in some sub-groups (potentially due to the Type I error or multiple testing). WIDER IMPLICATIONS OF THE FINDINGS: In this large study, after multivariable maternal adjustments, a moderately increased risk of defects subsisted after IVF, while those associated with IUI were no longer significant. In addition, our results showed that underlying maternal infertility could contribute to the increased risk of defects associated with IVF. These novel findings highlight the importance of taking into account the ART treatment methods and the type of infertility. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by the National Agency of Biomedicine. The authors have no competing interests to disclose. TRIAL REGISTRATION NUMBER: NA.
引用
- Fauque P, De Mouzon J, Devaux A, et al. Do in vitro fertilization, intrauterine insemination or female infertility impact the risk of congenital anomalies in singletons? A longitudinal national French study. Hum Reprod. 2021. PMID: 33378527. doi:10.1093/humrep/deaa323
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。